Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Incyte
Biotech
Incyte, FDA, Sun Pharma and more—Chutes & Ladders
Incyte CEO passes the baton to veteran dealmaker. String of FDA leadership shake-ups continues. Sun Pharma sees future with new North America CEO.
Zoey Becker
,
Gabrielle Masson
Jun 27, 2025 8:30am
Incyte posts phase 3 skin condition wins but details disappoint
Mar 17, 2025 8:12am
Incyte pens $885M AI pact to use Genesis' GEMS to develop drugs
Feb 20, 2025 8:00am
Incyte exits cancer pact, leaving Agenus weighing its options
Feb 11, 2025 7:55am
Incyte scraps cancer-related anemia program after ph. 1/2 fail
Dec 13, 2024 2:30pm
Incyte's $750M buyout rocked by pause on key trial, asset cull
Nov 19, 2024 4:12am